myeloma

Johnson & Johnson (J&J) has taken a significant step towards gaining FDA approval for its CAR-T therapy, Carvykti, in the treatment of multiple myeloma

Johnson & Johnson (J&J) Moves Closer to FDA Approval for CAR-T Therapy

SG Tylor

The company has filed for approval to use Carvykti earlier in the treatment pathway, including for patients experiencing their first ...